Biologics Error Reports May Include Events Not In Validation Protocols - FDA
Unvalidated biologics manufacturing errors and accidents may need to be reported to FDA even if a firm determines the lapses do not affect the safety, purity or efficacy of the product.
You may also be interested in...
FDA should do more to communicate information regarding the use of hormone therapy, the fiscal 2003 omnibus appropriations bill urges
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011